← Eichor
Condition: Parkinson S Disease Psychosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Parkinson S Disease Psychosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Phase 4 · 24 location(s) · VA Office of Research and Development · NCT04373317Clozapine-related Immunodeficiency in Parkinsons Disease
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06634641Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05590637Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
Phase 2 · 1 location(s) · Johns Hopkins University · NCT05824728
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.